Amdocs Limited $DOX Shares Acquired by LSV Asset Management

LSV Asset Management increased its stake in shares of Amdocs Limited (NASDAQ:DOX) by 7.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,648,703 shares of the technology company’s stock after buying an additional 257,193 shares during the quarter. LSV Asset Management owned about 3.23% of Amdocs worth $299,376,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in DOX. MQS Management LLC purchased a new position in Amdocs in the third quarter worth $824,000. Versor Investments LP purchased a new stake in shares of Amdocs during the 3rd quarter worth $1,182,000. Navellier & Associates Inc. acquired a new position in shares of Amdocs during the 3rd quarter worth $232,000. Johnson Investment Counsel Inc. increased its holdings in shares of Amdocs by 1.0% in the 3rd quarter. Johnson Investment Counsel Inc. now owns 20,081 shares of the technology company’s stock valued at $1,648,000 after purchasing an additional 200 shares in the last quarter. Finally, Fullcircle Wealth LLC increased its holdings in shares of Amdocs by 8.7% in the 3rd quarter. Fullcircle Wealth LLC now owns 3,102 shares of the technology company’s stock valued at $259,000 after purchasing an additional 248 shares in the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.

Amdocs Trading Down 4.2%

NASDAQ:DOX opened at $70.05 on Thursday. Amdocs Limited has a 12-month low of $69.47 and a 12-month high of $95.41. The firm has a market capitalization of $7.56 billion, a P/E ratio of 13.55, a P/E/G ratio of 1.30 and a beta of 0.40. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.06 and a quick ratio of 1.17. The business has a 50 day simple moving average of $79.95 and a 200 day simple moving average of $81.99.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.06. The company had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.15 billion. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The company’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.66 earnings per share. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Equities research analysts predict that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Tuesday, March 31st will be issued a dividend of $0.569 per share. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.2%. This is a boost from Amdocs’s previous quarterly dividend of $0.53. The ex-dividend date of this dividend is Tuesday, March 31st. Amdocs’s dividend payout ratio is presently 40.81%.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on DOX shares. Barclays decreased their price objective on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday, February 4th. Stifel Nicolaus reduced their price target on shares of Amdocs from $97.00 to $88.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Wall Street Zen raised Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Bank of America dropped their price objective on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research note on Wednesday, November 12th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amdocs in a report on Tuesday, January 27th. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $92.33.

Amdocs Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.